Brain iron and ferritin in Parkinson’s and Alzheimer’s diseases

Jellinger, K., Paulus, W., Grundke-Iqbal, I., Riederer, P., Youdim, M. B. H.·1990·Journal of Neural Transmission - Parkinson's Disease and Dementia Section

DOI 10.1007/bf02252926

Cited by (445)

Items 201–300 of 445

M30, a novel multifunctional neuroprotective drug with potent iron chelating and brain selective monoamine oxidase-ab inhibitory activity for Parkinson’s disease
Gal, S., Fridkin, M., Amit, T., Zheng, H., Youdim, M. B. H. · 2006 · Parkinson’s Disease and Related Disorders
Age-related regulation of dendritic endocytosis associated with altered clathrin dynamics
Thomas A. Blanpied · 2003 · Neurobiology of Aging
Iron-related nigral degeneration influences functional topology mediated by striatal dysfunction in Parkinson's disease
Xiaojun Guan, Yuyao Zhang, Hongjiang Wei, Tao Guo, Qiaoling Zeng, Cheng Zhou, Jiaqiu Wang, Ting Gao, Min Xuan, Quanquan Gu et al. · 2018 · Neurobiology of Aging
Comparative techniques for determining cellular iron distribution in brain tissues
Daniel P. Perl, Paul F. Good · 1992 · Annals of Neurology
Iron stored in ferritin is chemically reduced in the presence of aggregating Aβ(1-42)
James L. Everett, Jake Brooks, Frederik Lermyte, Peter B. O’Connor, Peter John Sadler, Jon Dobson, Joanna F. Collingwood, Neil D. Telling · 2020 · Scientific Reports
The utility of iron chelators in the management of inflammatory disorders
Lehmann, C., Islam, S., Jarosch, S., Zhou, J., Hoskin, D., Greenshields, A., Al-Banna, N., Sharawy, N., Sczcesniak, A., Kelly, M. et al. · 2015 · Mediators of Inflammation
Identification of L-ferritin in Neuromelanin Granules of the Human Substantia Nigra
Florian Tribl, Esther Asan, Thomas Arzberger, Thomas Tatschner, Elmar Langenfeld, Helmut E. Meyer, Gerhard Bringmann, Peter Franz Riederer, Manfred Gerlach, Katrin Marcus · 2009 · Molecular & Cellular Proteomics
Iron Pathophysiology in Parkinson Diseases.
Hong Jiang, N. Song, Q. Jiao, Li-Min Shi, Xi-Xun Du · 2019 · Advances in Experimental Medicine and Biology
Catechol releases iron( iii ) from ferritin by direct chelation without iron( ii ) production
Purificación Sánchez, Natividad Gálvez, Enrique Colacio, Elena Miñones-Moyano, Jose Manuel Dominguez-Vera · 2005 · Dalton Transactions
Ki-M1P as a marker for microglia and brain macrophages in routinely processed human tissues
Werner Paulus, Wolfgang Roggendorf, Thomas Kirchuer · 1992 · Acta Neuropathologica
Cerebrospinal fluid ferritin levels of patients with Parkinson's disease, Alzheimer's disease, and multiple system atrophy
Michael A. Kuiper, Cees Mulder, Gerard J. van Kamp, Philip Scheltens, Erik Ch. Wolters · 1994 · Journal of Neural Transmission - Parkinsons Disease and Dementia Section
Cortical iron regulation and inflammatory response in Alzheimer's disease and APPSWE/PS1ΔE9 mice: a histological perspective
Meadowcroft, Mark D., Connor, James R., Yang, Qing X. · 2015 · Frontiers in Neuroscience
Metal specificity of an iron-responsive element in Alzheimer’s APP mRNA 5′untranslated region, tolerance of SH-SY5Y and H4 neural cells to desferrioxamine, clioquinol, VK-28, and a piperazine chelator
Sanghamitra Bandyopadhyay, Xudong Huang, Hannah K Cho, Nigel H. Greig, Moussa B. H. Youdim, Jack T. Rogers · 2006 · Springer eBooks
In vivo assessment of iron content of the cerebral cortex in healthy aging using 7-Tesla T2*-weighted phase imaging
Mathijs Buijs, Nhat Trung Doan, Sanneke van Rooden, Maarten J. Versluis, Baldur van Lew, Julien Milles, Jeroen van der Grond, Mark A. van Buchem · 2016 · Neurobiology of Aging
Overdosing on iron: Elevated iron and degenerative brain disorders
Santosh R. D’Mello, Mark S. Kindy · 2020 · Experimental Biology and Medicine
Pathogenesis and preclinical course of Parkinson’s disease
Peter Foley, Peter Franz Riederer · 1999 · Journal of neural transmission. Supplementum
Oxygen Free Radicals and Neurodegeneration in Parkinson's Disease: A Role for Nitric Oxidea
Moussa B. H. Youdim, Lena Lavie, Peter Franz Riederer · 1994 · Annals of the New York Academy of Sciences
Quantitative comparison of different iron forms in the temporal cortex of Alzheimer patients and control subjects
Marjolein Bulk, Louise van der Weerd, Wico Breimer, Н. А. Лебедев, ANDREW G. WEBB, Jelle J. Goeman, Roberta J. Ward, Martina Huber, Tjerk H. Oosterkamp, Lucia Bossoni · 2018 · Scientific Reports
Interplay of Ferritin Accumulation and Ferroportin Loss in Ageing Brain: Implication for Protein Aggregation in Down Syndrome Dementia, Alzheimer’s, and Parkinson’s Diseases
Animesh Alexander Raha, Anwesha Biswas, James W. Henderson, Subhojit Chakraborty, Anthony John Holland, Robert Paul Friedland, Elizabeta Blagoja Mukaetova-Ladinska, Shahid H. Zaman, Ruma Raha‐Chowdhury · 2022 · International Journal of Molecular Sciences
Blood transferrin and ferritin in Alzheimer's disease
Peter A. Fischer, Mario E. Götz, Walter Danielczyk, Wieland Gsell, Peter Franz Riederer · 1997 · Life Sciences
Alzheimer’s Disease, Neuroprotection, and CNS Immunosenescence
Wolfgang J. Streit, Qing‐Shan Xue · 2012 · Frontiers in Pharmacology
Iron-related gene variants and brain iron in multiple sclerosis and healthy individuals
Jesper Hagemeier, Murali Krishna Ramanathan, Ferdinand Schweser, Michael G. Dwyer, Fuchun Lin, Niels Bergsland, Bianca Weinstock‐Guttman, Robert Zivadinov · 2017 · NeuroImage Clinical
Role of Iron in the Molecular Pathogenesis of Diseases and Therapeutic Opportunities
Usama Abbasi, Srinivas Abbina, Arshdeep Gill, Lily E. Takuechi, Jayachandran N. Kizhakkedathu · 2021 · ACS Chemical Biology
The Application of Proteomics and Genomics to the Study of Age-Related Neurodegeneration and Neuroprotection
Orly Weinreb, Noam Driguès, Yotam Sagi, Abraham Zeev Reznick, Tamar Amit, Moussa B. H. Youdim · 2006 · Antioxidants and Redox Signaling
Label-free and real-time detection of ferritin using a horn-like polycrystalline-silicon nanowire field-effect transistor biosensor
Li-Chen Yen, Tung Ming Pan, Chiang-Hsuan Lee, Tien‐Sheng Chao · 2016 · Sensors and Actuators B Chemical
Is microglial dystrophy a form of cellular senescence? An analysis of senescence markers in the aged human brain
Pauline Neumann, Dana E. Lenz, Wolfgang J. Streit, Ingo Bechmann · 2022 · Glia
Nitric Oxide Protects Astrocytes from Oxidative Stress
S.J. Robb, James R. Connor · 2002 · Annals of the New York Academy of Sciences
Widespread Decreases in Cerebral Copper Are Common to Parkinson's Disease Dementia and Alzheimer's Disease Dementia
Melissa Scholefield, Stephanie J. Church, Jingshu Xu, Stefano Patassini, Federico Roncaroli, Nigel M. Hooper, Richard D. Unwin, Garth J. S. Cooper · 2021 · Frontiers in Aging Neuroscience
The role of monoamine oxidase, iron-melanin interaction, and intracellular calcium in Parkinson’s disease
Moussa B. H. Youdim, Dorit Ben‐Shachar, Peter Franz Riederer · 1990 · Springer eBooks
Efficacy of the iron‐chelating agent, deferiprone, in patients with Parkinson's disease: A systematic review and meta‐analysis
Ahmed Negida, Nafisa M. Hassan, Heba Ahmed Aboeldahab, Youmna E. Zain, Yasmin Negida, Shirin Cadri, Nivin Cadri, Leslie Jameleh Cloud, Matthew J. Barrett, Brian D. Berman · 2024 · CNS Neuroscience & Therapeutics
Oxidative stress and iron imbalance in Alzheimer disease: How rust became the fuss!
Mark A. Smith · 2006 · Journal of Alzheimer s Disease
Translation Imaging in Parkinson’s Disease: Focus on Neuroinflammation
S. Belloli, M. Morari, Valentina Murtaj, S. Valtorta, R. Moresco, M. Gilardi · 2020 · Frontiers in Aging Neuroscience
Microglial reaction in Pick's disease
Paulus, Werner, Bancher, Christian, Jellinger, Kurt · 1993 · Neuroscience Letters
Ferritin oxidation and proteasomal degradation: Protection by antioxidants
Peter Voß, Ľubica Horáková, Manuela Jakstadt, Daniela Kiekebusch, Tilman Grune · 2006 · Free Radical Research
Oxidative Stress and Parkinson’s Disease
Gerald Cohen · 2006 · Kluwer Academic Publishers eBooks
Ferroptosis in Neurological Disease
Samuel David, Fari Ryan, Priya Jhelum, Antje Kroner · 2022 · The Neuroscientist
Iron Accumulation Is Not Homogenous among Patients with Parkinson’s Disease
Khashayar Dashtipour, Manju Liu, Camellia Kani, Pejman Dalaie, André Obenaus, Daniel B. Simmons, Nicole M. Gatto, Mehran Zarifi · 2015 · Parkinson s Disease
Ceruloplasmin/Transferrin Ratio Changes in Alzheimer′s Disease
Rosanna Squitti, Carlo Salustri, Mariacristina Siotto, Mariacarla Ventriglia, Fabrizio Vernieri, Domenico Lupoi, Emanuele Cassetta, Paolo Maria Rossini · 2010 · International Journal of Alzheimer s Disease
Early and late molecular events in neurodegeneration and neuroprotection in Parkinson’s disease MPTP model as assessed by cDNA microarray; the role of iron
Moussa B. H. Youdim, Edna Grünblatt, Yona Levites, Gila Maor, Silvia A. Mandel · 2002 · Neurotoxicity Research
Neuroprotective therapeutic strategies comparison of experimental and clinical results
Manfred Gerlach, Peter Franz Riederer, Moussa B. H. Youdim · 1995 · Biochemical Pharmacology
Ferritin: The role of aluminum in ferritin function
James T. Fleming, J G Joshi · 1991 · Neurobiology of Aging
Neurotoxicity and neuroprotection in Parkinson's disease
Klaus W. Lange, Moussa B. H. Youdim, Peter Franz Riederer · 1992 · PubMed
Cysteamine Pretreatment of the Astroglial Substratum (Mitochondrial Iron Sequestration) Enhances PC12 Cell Vulnerability to Oxidative Injury
Dov Frankel, Hyman M. Schipper · 1999 · Experimental Neurology
Iron-responsive-like elements and neurodegenerative ferroptosis
Jack T. Rogers, Catherine M. Cahill · 2020 · Learning & Memory
Ferritin levels in microglia depend upon activation: Modulation by reactive oxygen species
Jana Mehlhase, Jeanette Gieche, Rebecca Widmer, Tilman Grune · 2006 · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research
The Iron Chelator Deferiprone Improves the Phenotype in a Mouse Model of Tauopathy
Shalini S. Rao, Stuart D Portbury, Larissa Lago, Ashley Ian Bush, Paul Anthony Adlard · 2020 · Journal of Alzheimer s Disease
RETRACTED: The Iron Chelator Deferiprone Improves the Phenotype in a Mouse Model of Tauopathy1
Shalini S. Rao, Stuart D Portbury, Larissa Lago, Ashley Ian Bush, Paul Anthony Adlard · 2020 · Journal of Alzheimer s Disease · Retracted
What have we learnt from CDNA microarray gene expression studies about the role of iron in MPTP induced neurodegeneration and Parkinson’s disease?
Moussa B. H. Youdim · 2003 · Journal of neural transmission. Supplementum
Regulation of heme oxygenase-1 expression by dopamine in cultured C6 glioma and primary astrocytes
Jeffrey E. Schmidt, Kirsten D. Mertz, James I Morgan · 1999 · Molecular Brain Research
Potent neuroprotective and antioxidant activity of apomorphine in MPTP and 6-hydroxydopamine induced neurotoxicity
Edna Grünblatt, Silvia A. Mandel, Michael Gassen, Moussa B. H. Youdim · 1999 · Springer eBooks
What Process Causes Nigral Cell Death in Parkinson’s Disease?
Peter G. Jenner · 1992 · Neurologic Clinics
Welding-related brain and functional changes in welders with chronic and low-level exposure
Eun-Young Lee, Michael R. Flynn, Mechelle M. Lewis, Richard B. Mailman, Xuemei Huang · 2017 · NeuroToxicology
The Efficacy of Iron Chelators for Removing Iron from Specific Brain Regions and the Pituitary—Ironing out the Brain
Robert R. Crichton, Roberta J. Ward, Robert C. Hider · 2019 · Pharmaceuticals
Mucuna pruriens seeds in treatment of Parkinson’s disease: pharmacological review
Sanjay Bhaskar Kasture, Mahalaxmi Mohan, Veena Sanjay Kasture · 2013 · Oriental Pharmacy and Experimental Medicine
In vivo evaluation of microglia activation by intracranial iron overload in central pain after spinal cord injury
Fan Xing Meng, Jing Ming Hou, Tiansheng Sun · 2017 · Journal of Orthopaedic Surgery and Research
In situ hybridization for detection of nocardial 16S rRNA: reactivity within intracellular inclusions in experimentally infected cynomolgus monkeys—and in Lewy body-containing human brain specimens
Gail D. Chapman, Blaine L. Beaman, David A. Loeffler, Dianne M. Camp, Edward F. Domino, Dennis W. Dickson, William G. Ellis, Ibsen Chen, Susan E. Bachus, Peter A. LeWitt · 2003 · Experimental Neurology
The high‐affinity D2/D3 agonist D512 protects PC 12 cells from 6‐ OHDA ‐induced apoptotic cell death and rescues dopaminergic neurons in the MPTP mouse model of Parkinson's disease
Mrudang M. Shah, Subramanian Rajagopalan, Liping Xu, Chandrashekhar Voshavar, Yevgeniya I. Shurubor, Flint M. Beal, Julie Kay Andersen, Aloke K. Dutta · 2014 · Journal of Neurochemistry
Pathological evidence for oxidative stress in Parkinson's disease and related degenerative disorders
Peter G. Jenner, C. Warren Olanow · 1996 · Elsevier eBooks
Evaluation of iron overload in nigrosome 1 via quantitative susceptibility mapping as a progression biomarker in prodromal stages of synucleinopathies
Marta Lancione, Graziella Donatelli, Eleonora Del Prete, Nicole Campese, Daniela Frosini, Matteo Cencini, Mauro Costagli, Laura Biagi, Giacomo Lucchi, Michela Tosetti et al. · 2022 · NeuroImage
Metal Ions in Alzheimer's Disease Brain
Magdalena Sastre, Craig William Ritchie, Nabil Hajji · 2015
Variation in the concentration and regional distribution of magnetic nanoparticles in human brains, with and without Alzheimer’s disease, from the UK
Jessica Hammond, Barbara A. Maher, Imad A. M. Ahmed, David Allsop · 2021 · Scientific Reports
Ndfip1 attenuated 6-OHDA–induced iron accumulation via regulating the degradation of DMT1
Wenting Jia, Huamin Xu, Xixun Du, Hong Fu Jiang, Junxia Xie · 2014 · Neurobiology of Aging
Ferroportin1 and hephaestin overexpression attenuate iron‐induced oxidative stress in MES23.5 dopaminergic cells
Ning Song, Jun Wang, Hong Fu Jiang, Junxia Xie · 2010 · Journal of Cellular Biochemistry
Mitochondrial respiratory enzyme function and superoxide dismutase activity following brain glutathione depletion in the rat
Taylor A Seaton, Peter G. Jenner, C. DAVID MARSDEN · 1996 · Biochemical Pharmacology
Excessive Iron Induces Oxidative Stress Promoting Cellular Perturbations and Insulin Secretory Dysfunction in MIN6 Beta Cells
Voni Blesia, Vinood B. Patel, Hisham Al-Obaidi, Derek W. Renshaw, Mohammed Gulrez Zariwala · 2021 · Cells
Dialysis-associated encephalopathy: light and electron microscopic morphology and topography with evidence of aluminum by laser microprobe mass analysis
Erich Reusche, Ulrich Seydel · 1993 · Acta Neuropathologica
Current neuroimaging techniques in Alzheimer's disease and applications in animal models.
Linda Zhang, Raymond Chuen‐Chung Chang, Leung‐Wing Chu, Henry Ka‐Fung Mak · 2012 · Europe PMC (PubMed Central)
Switching on Endogenous Metal Binding Proteins in Parkinson’s Disease
Fleur Alice McLeary, Alexandre Nay Rcom-H'cheo-Gauthier, Michael Goulding, Rowan A. W. Radford, Yuho Okita, Peter Faller, Roger S. Chung, Dean L. Pountney · 2019 · Cells
Biomarkers for prediction and targeted prevention of Alzheimer’s and Parkinson’s diseases: evaluation of drug clinical efficacy
Silvia A. Mandel, Micaela Morelli, Ilan J. Y. Halperin, Amos D. Korczyn · 2010 · The EPMA Journal
The copper chelator, D-penicillamine, does not attenuate MPTP induced dopamine depletion in mice
Moussa B. H. Youdim, Edna Grünblatt, Silvia A. Mandel · 2006 · Journal of Neural Transmission
Biometals as Potential Predictors of the Neurodegenerative Decline in Alzheimer’s Disease.
Liseth Lavado, Michelle H. Zhang, Karan Patel, Sohim Khan, Urvish K. Patel · 2019 · Cureus
Over-expressed human divalent metal transporter 1 is involved in iron accumulation in MES23.5 cells
Huamin Xu, Hong Fu Jiang, Jun Wang, Bing Luo, Junxia Xie · 2007 · Neurochemistry International
Mitochondrial Abnormalities and Oxidative Imbalance in Neurodegenerative Disease
Osamu Ogawa, Xiongwei Zhu, George L. Perry, Mark A. Smith · 2002 · Science of Aging Knowledge Environment
Increased Hippocampal Expression of the Divalent Metal Transporter 1 (DMT1) mRNA Variants 1B and +IRE and DMT1 Protein After NMDA-Receptor Stimulation or Spatial Memory Training
Paola A. Haeger, Álvaro Álvarez, Nancy R. Leal, Tatiana Adasme, Marco Tulio Núñez, Cecilia Hidalgo · 2009 · Neurotoxicity Research
Is Chelation Therapy a Potential Treatment for Parkinson’s Disease?
R. Ward, D. Dexter, A. Martín-Bastida, R. Crichton · 2021 · International Journal of Molecular Sciences
Cerebral Microbleeds Are Associated With Increased Brain Iron and Cognitive Impairment in Patients With Cerebral Small Vessel Disease: A Quantitative Susceptibility Mapping Study
Jing Li, Thanh Duc Nguyen, Qihao Zhang, Lingfei Guo, Yi Wang · 2022 · Journal of Magnetic Resonance Imaging
Glycyrrhetinic acid and E.resveratroloside act as potential plant derived compounds against dopamine receptor D3 for Parkinson’s disease: a pharmacoinformatics study
Muhammad Usman Mirza, Ahmed Hammad Mirza, Noor-Ul-Huda Ghori, Saba Ferdous · 2014 · Drug Design Development and Therapy
Time course of dopaminergic cell death and changes in iron, ferritin and transferrin levels in the rat substantia nigra after 6-hydroxydopamine (6-OHDA) lesioning
Y. He, T. Lee, Seng Kee Leong · 1999 · Free Radical Research
Pharmacological and clinical implications of MAO-B inhibitors
Peter H. Yu · 1994 · General Pharmacology The Vascular System
Quantitative Susceptibility Mapping by Inversion of a Perturbation Field Model: Correlation With Brain Iron in Normal Aging
Clare B. Poynton, Mark Jenkinson, Elfar Adalsteinsson A, Edith V. Sullivan, Adolf Pfefferbaum, William M. Wells · 2014 · IEEE Transactions on Medical Imaging
Hybrid lanthanide nanoparticles as a new class of binary contrast agents for in vivo T 1 /T 2 dual-weighted MRI and synergistic tumor diagnosis
Zhigao Yi, Xiaolong Li, Wei Ming Lu, Hongrong Liu, Songjun Zeng, Jianhua Hao · 2016 · Journal of Materials Chemistry B
Ferritinophagy and α-Synuclein: Pharmacological Targeting of Autophagy to Restore Iron Regulation in Parkinson’s Disease
Matthew K. Boag, Angus Roberts, Vladimir Nikolaevich Uversky, Linlin Ma, Des Raymond Richardson, Dean L. Pountney · 2022 · International Journal of Molecular Sciences
Controversies about iron in parkinsonian and control substantia nigra
Jolanta Gałązka-Friedman, Andrzej Friedman · 1997 · Acta Neurobiologiae Experimentalis
Peripheral iron metabolism in patients with Parkinson's disease
Francisco Cabrera‐Valdivia, Félix Javier Jiménez‐Jiménez, JoséAntonio Molina, Pilar Fernández–Calle, Antonio Vázquez, F. Canizares-Liebana, Sagrario Larumbe-Lobalde, Lucía Ayuso‐Peralta, María Rabasa, Rosa Codoceo · 1994 · Journal of the Neurological Sciences
RETRACTED: Characterising the spatial and temporal brain metal profile in a mouse model of tauopathy
Shalini S. Rao, Larissa Lago, Raquel González de Vega, Lisa Bray, Dominic James Hare, David Clases, Philip Doble, Paul Anthony Adlard · 2019 · Metallomics · Retracted
Iron protects astrocytes from 6-hydroxydopamine toxicity
Nevena S. Zogovic, Aleksandra Mladenović, Milka Perović, Ljubica M. Harhaji-Trajkovic, Djordje M. Miljković, Vladimir Trajković · 2005 · Neuropharmacology
Movement disorders in the Hfe knockout mouse
Mari S. Golub, Stacey L. Germann, Renee S. Araiza, J. Rachel Reader, Stephen M. Griffey, K. C. Kent Lloyd · 2005 · Nutritional Neuroscience
The relevance of glial monoamine oxidase-B and polyamines to the action of selegiline in parkinson's disease
Moussa B. H. Youdim, Peter Franz Riederer · 1993 · Movement Disorders
Non-destructive imaging of an individual protein
Jean-Nicolas Longchamp, Tatiana Latychevskaia, Conrad Escher, Hans‐Werner Fink · 2012 · Applied Physics Letters
Impacts of Iron Metabolism Dysregulation on Alzheimer’s Disease
Najla Jouini, Zakaria Saied, Samia Ben Sassi, Fatma Nebli, Taieb Ben Messaoud, Fayçel Hentati, Samir Belal · 2021 · Journal of Alzheimer s Disease
Redox stress and metal dys-homeostasis appear as hallmarks of early prion disease pathogenesis in mice
Jereme G. Spiers, Hsiao‐Jou Cortina Chen, Tiffany L. Barry, Julie-Myrtille Bourgognon, Joern R. Steinert · 2022 · Free Radical Biology and Medicine
Control of the Surface Charges of Au−Ag Nanorods: Selective Detection of Iron in the Presence of Poly(sodium 4-styrenesulfonate)
Yu‐Fen Huang, Yang‐Wei Lin, Huan‐Tsung Chang · 2007 · Langmuir
Magnetic Resonance Imaging (MRI) to Study Striatal Iron Accumulation in a Rat Model of Parkinson’s Disease
Ana Virel, Erik Faergemann, Greger Orädd, Ingrid Strömberg · 2014 · PLoS ONE
Deferiprone Treatment in Aged Transgenic Tau Mice Improves Y-Maze Performance and Alters Tau Pathology
Shalini S. Rao, Larissa Lago, Irene Volitakis, Jay J. Shukla, Gawain McColl, David Isaac Finkelstein, Paul Anthony Adlard · 2021 · Neurotherapeutics · Retracted
Anti-oxidative stress and cognitive improvement of a semi-synthetic isoorientin-based GSK-3β inhibitor in rat pheochromocytoma cell PC12 and scopolamine-induced AD model mice via AKT/GSK-3β/Nrf2 pathway
Yijing Zhao, Changhong He, Shaozhen Hu, Haojie Ni, Xiaoqin Tan, Yingkun Zhi, Lang Yi, Risong Na, Yanwu Li, Qun Du et al. · 2024 · Experimental Neurology
Microglial senescence in neurodegeneration: Insights, implications, and therapeutic opportunities
Tobiloba Samuel Olajide, Toheeb Olalekan Oyerinde, Omolabake I. Omotosho, Oritoke Modupe Okeowo, Olayemi Joseph Olajide, Omamuyouwi M. Ijomone · 2024 · Neuroprotection/Neuroprotection (Chichester, England. Print)
Application of Synchrotron Radiation in Neuromicrobiology: Role of Iron in Parkinson's Disease
Sohei Yoshida, Ari Ide‐Ektessabi, Shigeyoshi Fujisawa · 2003 · Structural Chemistry
Does ultrasound disclose a vulnerability factor for Parkinson's disease?
Stefanie Behnke, Daniela Berg, Georg Becker · 2003 · Journal of Neurology
Preclinical and Potential Applications of Common Western Herbal Supplements as Complementary Treatment in Parkinson's Disease
Luke A. Morgan, Oliver Grundmann · 2017 · Journal of Dietary Supplements
Tau Pathology, Metal Dyshomeostasis and Repetitive Mild Traumatic Brain Injury: An Unexplored Link Paving the Way for Neurodegeneration
Sydney M. A. Juan, Maria Daglas, Paul Anthony Adlard · 2022 · Journal of Neurotrauma